Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Implant Sciences Corp (OTCQB:IMSC)

0.4121
Delayed Data
As of Aug 24
 -0.0079 / -1.89%
Today’s Change
0.23
Today|||52-Week Range
0.85
-19.20%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Electronic Equipment/Instruments
MARKET CAP
$33.2M

Company Description

Implant Sciences Corp. designs, manufactures, and sells explosives trace detection (ETD) and drugs trace detection solutions for multiple security applications including aviation, transportation, customs, air cargo, critical infrastructure protection, ports and borders, force protection, public safety and emergency responders. Its products include Quantum Sniffer QS-H150 portable explosives detector for the simultaneous detection of explosives particulates and vapors with or without physical contact and in real-time and Quantum Sniffer QS-B220 desktop explosives and narcotics detector for the detection and identification of various military, commercial and improvised explosives, as well as narcotics. The company was founded in August 1984 and is headquartered in Wilmington, MA.

Contact Information

Implant Sciences Corp.
500 Research Drive
Wilmington Massachusetts 01887-4437
P:(978) 752-1700
Investor Relations:
19787521700116

Employees

Shareholders

Individual stakeholders4.94%
Mutual fund holders--
Other institutional--

Top Executives

William J. McGannChief Executive Officer & Director
Robert P. LiscouskiPresident & Director
Todd A. SilvestriChief Operating Officer
Roger P. DeschenesChief Financial Officer & Vice President
Brenda L. BaronVice President-Manufacturing & Technical Services